PMC:7441777 / 229-2035
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T3 | 381-384 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T4 | 395-398 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T5 | 438-441 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T6 | 600-603 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 53-61 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 77-124 | Disease | denotes | Severe Acute Respiratory Syndrome Coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 126-134 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 244-252 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 371-379 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 427-435 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 810-818 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 862-870 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 1762-1770 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 144-145 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 604-611 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T3 | 690-691 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 888-889 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T5 | 1099-1102 | http://purl.obolibrary.org/obo/CLO_0009325 | denotes | TF1 |
T6 | 1262-1268 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T7 | 1292-1293 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 1545-1546 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 212-216 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T6 | 292-296 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T7 | 310-314 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T8 | 352-360 | Chemical | denotes | solution | http://purl.obolibrary.org/obo/CHEBI_75958 |
T9 | 490-504 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
T10 | 490-499 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T11 | 500-504 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T12 | 550-561 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T13 | 631-642 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T14 | 793-804 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T15 | 901-912 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T16 | 1081-1085 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T17 | 1087-1097 | Chemical | denotes | theaflavin | http://purl.obolibrary.org/obo/CHEBI_136609 |
T18 | 1105-1115 | Chemical | denotes | theaflavin | http://purl.obolibrary.org/obo/CHEBI_136609 |
T19 | 1121-1128 | Chemical | denotes | gallate | http://purl.obolibrary.org/obo/CHEBI_16918 |
T20 | 1137-1147 | Chemical | denotes | theaflavin | http://purl.obolibrary.org/obo/CHEBI_136609 |
T21 | 1151-1158 | Chemical | denotes | gallate | http://purl.obolibrary.org/obo/CHEBI_16918 |
T22 | 1167-1192 | Chemical | denotes | theaflavin 3,3'-digallate | http://purl.obolibrary.org/obo/CHEBI_136608 |
T23 | 1167-1177 | Chemical | denotes | theaflavin | http://purl.obolibrary.org/obo/CHEBI_136609 |
T24 | 1183-1192 | Chemical | denotes | digallate | http://purl.obolibrary.org/obo/CHEBI_17866 |
T25 | 1194-1197 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
T26 | 1200-1210 | Chemical | denotes | hesperidin | http://purl.obolibrary.org/obo/CHEBI_28775 |
T27 | 1212-1225 | Chemical | denotes | quercetagetin | http://purl.obolibrary.org/obo/CHEBI_8695 |
T28 | 1231-1240 | Chemical | denotes | myricetin | http://purl.obolibrary.org/obo/CHEBI_18152|http://purl.obolibrary.org/obo/CHEBI_58395 |
T30 | 1344-1348 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T31 | 1362-1365 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
T32 | 1474-1476 | Chemical | denotes | MM | http://purl.obolibrary.org/obo/CHEBI_53458|http://purl.obolibrary.org/obo/CHEBI_74707 |
T34 | 1684-1688 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T35 | 1702-1705 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 438-453 | http://purl.obolibrary.org/obo/GO_0039703 | denotes | RNA replication |
T2 | 740-751 | http://purl.obolibrary.org/obo/GO_0042592 | denotes | homeostasis |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
44 | 411-415 | Gene | denotes | RdRp | Gene:43740578 |
45 | 586-590 | Gene | denotes | RdRp | Gene:43740578 |
46 | 821-825 | Gene | denotes | RdRp | Gene:43740578 |
47 | 1044-1048 | Gene | denotes | RdRp | Gene:43740578 |
48 | 1160-1164 | Gene | denotes | TF2b | Gene:2959 |
49 | 1277-1281 | Gene | denotes | RdRp | Gene:43740578 |
50 | 1356-1360 | Gene | denotes | TF2b | Gene:2959 |
51 | 1415-1419 | Gene | denotes | RdRp | Gene:43740578 |
52 | 1696-1700 | Gene | denotes | TF2b | Gene:2959 |
53 | 1718-1722 | Gene | denotes | RdRp | Gene:43740578 |
54 | 77-124 | Species | denotes | Severe Acute Respiratory Syndrome Coronavirus 2 | Tax:2697049 |
55 | 126-136 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
56 | 427-437 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
57 | 810-820 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
58 | 550-561 | Chemical | denotes | polyphenols | MESH:D059808 |
59 | 631-642 | Chemical | denotes | polyphenols | MESH:D059808 |
60 | 793-804 | Chemical | denotes | polyphenols | MESH:D059808 |
61 | 901-912 | Chemical | denotes | polyphenols | MESH:D059808 |
62 | 1081-1085 | Chemical | denotes | EGCG | MESH:C045651 |
63 | 1087-1097 | Chemical | denotes | theaflavin | MESH:C056068 |
64 | 1105-1128 | Chemical | denotes | theaflavin-3’-O-gallate | |
65 | 1137-1158 | Chemical | denotes | theaflavin-3’-gallate | |
66 | 1167-1192 | Chemical | denotes | theaflavin 3,3'-digallate | MESH:C585473 |
67 | 1194-1197 | Chemical | denotes | TF3 | MESH:C585473 |
68 | 1200-1210 | Chemical | denotes | hesperidin | MESH:D006569 |
69 | 1212-1225 | Chemical | denotes | quercetagetin | MESH:C079163 |
70 | 1231-1240 | Chemical | denotes | myricetin | MESH:C040015 |
71 | 1344-1348 | Chemical | denotes | EGCG | MESH:C045651 |
72 | 1477-1481 | Chemical | denotes | PBSA | MESH:C437084 |
73 | 1568-1572 | Chemical | denotes | ADME | |
74 | 1684-1688 | Chemical | denotes | EGCG | MESH:C045651 |
75 | 32-51 | Disease | denotes | Coronavirus disease | MESH:D018352 |
76 | 53-61 | Disease | denotes | COVID-19 | MESH:C000657245 |
77 | 244-252 | Disease | denotes | COVID-19 | MESH:C000657245 |
78 | 371-379 | Disease | denotes | COVID-19 | MESH:C000657245 |
79 | 862-870 | Disease | denotes | COVID-19 | MESH:C000657245 |
80 | 1585-1593 | Disease | denotes | toxicity | MESH:D064420 |
81 | 1762-1770 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T1 | 1099-1102 | GlycoEpitope | denotes | TF1 | http://www.glycoepitope.jp/epitopes/AN0049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 0-8 | Sentence | denotes | Abstract |
T7 | 9-185 | Sentence | denotes | The sudden outburst of Coronavirus disease (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses a massive threat to global public health. |
T8 | 186-253 | Sentence | denotes | Currently, no therapeutic drug or vaccine exists to treat COVID-19. |
T9 | 254-380 | Sentence | denotes | Due to the time taking process of new drug development, drug repurposing might be the only viable solution to tackle COVID-19. |
T10 | 381-512 | Sentence | denotes | RNA‐dependent RNA polymerase (RdRp) catalyzes SARS-CoV-2 RNA replication and hence, is an obvious target for antiviral drug design. |
T11 | 513-612 | Sentence | denotes | Interestingly, several plant-derived polyphenols effectively inhibit the RdRp of other RNA viruses. |
T12 | 613-752 | Sentence | denotes | More importantly, polyphenols have been used as dietary supplementations for a long time and played beneficial roles in immune homeostasis. |
T13 | 753-871 | Sentence | denotes | We were curious to study the binding of polyphenols with SARS-CoV-2 RdRp and assess their potential to treat COVID-19. |
T14 | 872-986 | Sentence | denotes | Herein, we made a library of polyphenols that have shown substantial therapeutic effects against various diseases. |
T15 | 987-1049 | Sentence | denotes | They were successfully docked in the catalytic pocket of RdRp. |
T16 | 1050-1282 | Sentence | denotes | The investigation reveals that EGCG, theaflavin (TF1), theaflavin-3’-O-gallate (TF2a), theaflavin-3’-gallate (TF2b), theaflavin 3,3'-digallate (TF3), hesperidin, quercetagetin, and myricetin strongly bind to the active site of RdRp. |
T17 | 1283-1420 | Sentence | denotes | Further, a 150-ns molecular dynamic simulation revealed that EGCG, TF2a, TF2b, TF3 result in highly stable bound conformations with RdRp. |
T18 | 1421-1526 | Sentence | denotes | The binding free energy components calculated by the MM-PBSA also confirm the stability of the complexes. |
T19 | 1527-1649 | Sentence | denotes | We also performed a detailed analysis of ADME prediction, toxicity prediction, and target analysis for their druggability. |
T20 | 1650-1771 | Sentence | denotes | Overall, our results suggest that EGCG, TF2a, TF2b, TF3 can inhibit RdRp and represent an effective therapy for COVID-19. |
T21 | 1772-1800 | Sentence | denotes | Communicated by Ramaswamy H. |
T22 | 1801-1806 | Sentence | denotes | Sarma |